check_circleStudy Completed

Acne vulgaris

Bayer Identifier:

Trial_307760

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate the safety and efficacy of ethinylestradiol / dienogest in female patients with papulopustular acne in comparison to ethinylestradiol / cyproterone acetate and placebo

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
1326
Trial Dates
March 2004 - May 2005
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Valette (Dienogest/EE30, BAY86-5038)
Accepts Healthy Volunteer
N/A

Trial design

Multicenter, double-blind, double-dummy, randomized parallel group study to evaluate the safety and efficacy of 0.030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with papulopustular acne in comparison to 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and placebo
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A